Remdesivir, a drug made by Gilead, is showing some promise in fighting Covid-19 by reducing by four days the recovery time, according to the New York Times.
The drug was developed to fight Ebola, but didn’t work well in trials in Africa. Earlier tests of the drug didn’t prove that the drug had much effect, but showed that it caused no harm and was safe to take.
In this latest trial, 1,063 patients with Covid-19 were given either remdesivir or a placebo. For those who received remdesivir,